Literature DB >> 24160353

Drug repositioning from bench to bedside: tumour remission by the antihelmintic drug mebendazole in refractory metastatic colon cancer.

Peter Nygren1, Rolf Larsson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24160353     DOI： 10.3109/0284186X.2013.844359

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  29 in total

1.  Targeting acute myeloid leukemia by drug-induced c-MYB degradation.

Authors:  V Walf-Vorderwülbecke; K Pearce; T Brooks; M Hubank; M M van den Heuvel-Eibrink; C M Zwaan; S Adams; D Edwards; J Bartram; S Samarasinghe; P Ancliff; A Khwaja; N Goulden; G Williams; J de Boer; O Williams
Journal:  Leukemia       Date:  2017-11-01       Impact factor: 11.528

Review 2.  Drug repurposing in oncology--patient and health systems opportunities.

Authors:  Francesco Bertolini; Vikas P Sukhatme; Gauthier Bouche
Journal:  Nat Rev Clin Oncol       Date:  2015-10-20       Impact factor: 66.675

3.  Mebendazole and radiation in combination increase survival through anticancer mechanisms in an intracranial rodent model of malignant meningioma.

Authors:  Christine G Skibinski; Tara Williamson; Gregory J Riggins
Journal:  J Neurooncol       Date:  2018-11-09       Impact factor: 4.130

4.  Repurposing the antihelmintic mebendazole as a hedgehog inhibitor.

Authors:  Andrew R Larsen; Ren-Yuan Bai; Jon H Chung; Alexandra Borodovsky; Charles M Rudin; Gregory J Riggins; Fred Bunz
Journal:  Mol Cancer Ther       Date:  2014-11-05       Impact factor: 6.261

Review 5.  Implications of the small number of distinct ligand binding pockets in proteins for drug discovery, evolution and biochemical function.

Authors:  Jeffrey Skolnick; Mu Gao; Ambrish Roy; Bharath Srinivasan; Hongyi Zhou
Journal:  Bioorg Med Chem Lett       Date:  2015-02-03       Impact factor: 2.823

6.  Repurposing Drugs in Oncology (ReDO)-nitroglycerin as an anti-cancer agent.

Authors:  Vidula Sukhatme; Gauthier Bouche; Lydie Meheus; Vikas P Sukhatme; Pan Pantziarka
Journal:  Ecancermedicalscience       Date:  2015-08-27

7.  Repurposing Drugs in Oncology (ReDO)-itraconazole as an anti-cancer agent.

Authors:  Pan Pantziarka; Vidula Sukhatme; Gauthier Bouche; Lydie Meheus; Vikas P Sukhatme
Journal:  Ecancermedicalscience       Date:  2015-04-15

8.  Identification of flubendazole as potential anti-neuroblastoma compound in a large cell line screen.

Authors:  Martin Michaelis; Bishr Agha; Florian Rothweiler; Nadine Löschmann; Yvonne Voges; Michel Mittelbronn; Tatjana Starzetz; Patrick N Harter; Behnaz A Abhari; Simone Fulda; Frank Westermann; Kristoffer Riecken; Silvia Spek; Klaus Langer; Michael Wiese; Wilhelm G Dirks; Richard Zehner; Jaroslav Cinatl; Mark N Wass; Jindrich Cinatl
Journal:  Sci Rep       Date:  2015-02-03       Impact factor: 4.379

Review 9.  Identifying Novel Actionable Targets in Colon Cancer.

Authors:  Maria Grazia Cerrito; Emanuela Grassilli
Journal:  Biomedicines       Date:  2021-05-20

10.  Repurposing Drugs in Oncology (ReDO)-mebendazole as an anti-cancer agent.

Authors:  Pan Pantziarka; Gauthier Bouche; Lydie Meheus; Vidula Sukhatme; Vikas P Sukhatme
Journal:  Ecancermedicalscience       Date:  2014-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.